Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Infranity in connection with the acquisition of Nordic Re-Finance AB
Mandate

Vinge advises Infranity in connection with the acquisition of Nordic Re-Finance AB

January 20, 2025 Employment and Benefits M&A Data protection and processing of personal data FDI Intellectual Property Corporate Tax Banking and Finance

Vinge has advised Infranity, a private equity firm specializing in infrastructure investments, in connection with its acquisition of a majority stake in Nordic Re-Finance AB, a Scandinavian locomotives lessor. The acquisition brings ambitious development plans for Nordic Re-Finance AB, including expansion into new geographical areas.

The transaction is subject to regulatory approvals and is expected to close in Q1 2025.

Vinge’s team consisted of among other Matthias Pannier, Ulrich Ziche, Robin Sultani and Sara Hammond (M&A), Calle Tengwall Pagels and Julia Gudmundsson (Banking and Finance, Jolene Reimerson, Christoffer Nordin, Katja Häglund and Nicklas Thorgerzon (Commercial Contracts, IT and GDPR), Victor Ericsson, Erik Kochbati, Tobias Fleischer, Ellenor Eckerborn and Marcus Svärd (Tax), Alice Göransson and Gulestan Ali (Employment), Tobias Kempas and Rebecka Målquist (IP), Daniel Wendelsson, Alva Chambert and Martin Hammarskiöld (FDI) and Julia Ulander Kull (Transaction Support).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025